E. Zakirova
Preclinical Research of Mesenchymal Stem Cell-Based Therapy for Ocular Diseases
Zakirova, E.; Aimaletdinov, A. M.; Malanyeva, A. G.; Rutland, С. S.; Rizvanov, A. A.
Authors
A. M. Aimaletdinov
A. G. Malanyeva
Professor CATRIN RUTLAND CATRIN.RUTLAND@NOTTINGHAM.AC.UK
PROFESSOR OF MOLECULAR MEDICINE
A. A. Rizvanov
Contributors
Khawaja H. Haider
Editor
Abstract
Mesenchymal stem cells (MSC) are specific cell types that enable tissue renewal within the body and are activated during the regeneration processes in response to injury. These cells are present in all human and animal tissues. In medical and biological research, MSCs are isolated and purified from the donor organism and cultured in vitro before use in the treatment of a variety of diseases and conditions associated with tissue damage and cell loss, including ocular lesions. This approach is called cell-based therapy or regenerative medicine. Despite the many existing therapeutic strategies in the area of cell therapy in relation to curing ocular diseases in recent years, advances and new regenerative therapy methods have also been developed and consolidated, giving us a new perspective. Therefore, it is necessary to implement standardization and comparison of cell therapy results. Experimentation using animal models has played a central role in biomedical research. The safety and efficacy of new drugs are usually tested in animal models of human diseases prior to entering human clinical trials. Nevertheless, the pathophysiological mechanisms of eye diseases are complex and multifactorial; hence it is crucial that experimental animal models with clinical relevance provide adequate information and sufficiently replicate the eye diseases being assessed and demonstrate the effects of MSC therapy.
Citation
Zakirova, E., Aimaletdinov, A. M., Malanyeva, A. G., Rutland, С. S., & Rizvanov, A. A. (2022). Preclinical Research of Mesenchymal Stem Cell-Based Therapy for Ocular Diseases. In K. H. Haider (Ed.), Handbook of Stem Cell Therapy (1-25). Springer Singapore. https://doi.org/10.1007/978-981-16-6016-0_12-1
Online Publication Date | Apr 5, 2022 |
---|---|
Publication Date | 2022 |
Deposit Date | Apr 29, 2022 |
Pages | 1-25 |
Book Title | Handbook of Stem Cell Therapy |
ISBN | 9789811660160 |
DOI | https://doi.org/10.1007/978-981-16-6016-0_12-1 |
Public URL | https://nottingham-repository.worktribe.com/output/7839284 |
Publisher URL | https://link.springer.com/referenceworkentry/10.1007/978-981-16-6016-0_12-1 |
Contract Date | Nov 16, 2021 |
You might also like
The role of the ALKBH5 RNA demethylase in invasive breast cancer
(2024)
Journal Article
Epitranscriptomic mechanisms of androgen signalling and prostate cancer
(2024)
Journal Article
Changes in Immune Response during Pig Gestation with a Focus on Cytokines
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search